A detailed history of Pure Financial Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Pure Financial Advisors, LLC holds 2,645 shares of NVS stock, worth $324,303. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,645
Previous 3,511 24.67%
Holding current value
$324,303
Previous $424,000 20.05%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 17, 2025

SELL
$113.5 - $129.73 $98,291 - $112,346
-866 Reduced 24.67%
2,645 $339,000
Q2 2025

Jul 18, 2025

BUY
$101.96 - $121.01 $357,981 - $424,866
3,511 New
3,511 $424,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $264B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Pure Financial Advisors, LLC Portfolio

Follow Pure Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pure Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pure Financial Advisors, LLC with notifications on news.